These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 32262201)

  • 41. Hyaluronic acid-decorated dual responsive nanoparticles of Pluronic F127, PLGA, and chitosan for targeted co-delivery of doxorubicin and irinotecan to eliminate cancer stem-like cells.
    Wang H; Agarwal P; Zhao S; Xu RX; Yu J; Lu X; He X
    Biomaterials; 2015 Dec; 72():74-89. PubMed ID: 26344365
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Loading of some quinoxaline derivatives in poly (l-lactic) acid/Pluronic® F-127 nanofibers enhances their anticancer efficiency and induces a p53 and p21 apoptotic-signaling pathway.
    El-Aassar MR; Saad EA; Habib SA; Waly HM
    Colloids Surf B Biointerfaces; 2019 Nov; 183():110444. PubMed ID: 31446323
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Angiopep-2-Conjugated "Core-Shell" Hybrid Nanovehicles for Targeted and pH-Triggered Delivery of Arsenic Trioxide into Glioma.
    Tao J; Fei W; Tang H; Li C; Mu C; Zheng H; Li F; Zhu Z
    Mol Pharm; 2019 Feb; 16(2):786-797. PubMed ID: 30620881
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Angiopep-2 modified PE-PEG based polymeric micelles for amphotericin B delivery targeted to the brain.
    Shao K; Huang R; Li J; Han L; Ye L; Lou J; Jiang C
    J Control Release; 2010 Oct; 147(1):118-26. PubMed ID: 20609375
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of flow on targeting and penetration of angiopep-decorated nanoparticles in a microfluidic model blood-brain barrier.
    Papademetriou I; Vedula E; Charest J; Porter T
    PLoS One; 2018; 13(10):e0205158. PubMed ID: 30300391
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Recombinant expressing angiopep-2 fused anti-VEGF single chain Fab (scFab) could cross blood-brain barrier and target glioma.
    Ji X; Wang H; Chen Y; Zhou J; Liu Y
    AMB Express; 2019 Oct; 9(1):165. PubMed ID: 31617104
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Superparamagnetic Iron Oxide Nanorod Carriers for Paclitaxel Delivery in the Treatment and Imaging of Colon Cancer in Mice.
    Dehvari K; Chen Y; Tsai YH; Tseng SH; Lin KS
    J Biomed Nanotechnol; 2016 Sep; 12(9):1734-45. PubMed ID: 29345885
    [TBL] [Abstract][Full Text] [Related]  

  • 48. PEGylated Nanoemulsions for Oral Delivery: Role of the Inner Core on the Final Fate of the Formulation.
    Santander-Ortega MJ; Plaza-Oliver M; Rodríguez-Robledo V; Castro-Vázquez L; Villaseca-González N; González-Fuentes J; Cano EL; Marcos P; Lozano MV; Arroyo-Jiménez MM
    Langmuir; 2017 May; 33(17):4269-4279. PubMed ID: 28391698
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Co-delivery of doxorubicin and siRNA for glioma therapy by a brain targeting system: angiopep-2-modified poly(lactic-co-glycolic acid) nanoparticles.
    Wang L; Hao Y; Li H; Zhao Y; Meng D; Li D; Shi J; Zhang H; Zhang Z; Zhang Y
    J Drug Target; 2015; 23(9):832-46. PubMed ID: 25856302
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Dual targeting effect of Angiopep-2-modified, DNA-loaded nanoparticles for glioma.
    Huang S; Li J; Han L; Liu S; Ma H; Huang R; Jiang C
    Biomaterials; 2011 Oct; 32(28):6832-8. PubMed ID: 21700333
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Thermogelling aqueous fluids containing low concentrations of Pluronic F127 and laponite nanoparticles.
    Sun K; Raghavan SR
    Langmuir; 2010 Jun; 26(11):8015-20. PubMed ID: 20408582
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Enhancement on oral absorption of paclitaxel by multifunctional pluronic micelles.
    Li Y; Bi Y; Xi Y; Li L
    J Drug Target; 2013 Feb; 21(2):188-99. PubMed ID: 23126604
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Evaluation of the effect of a gamma irradiated DBM-pluronic F127 composite on bone regeneration in Wistar rat.
    Al Kayal T; Panetta D; Canciani B; Losi P; Tripodi M; Burchielli S; Ottoni P; Salvadori PA; Soldani G
    PLoS One; 2015; 10(4):e0125110. PubMed ID: 25897753
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Targeted Imaging of Brain Tumors with a Framework Nucleic Acid Probe.
    Tian T; Li J; Xie C; Sun Y; Lei H; Liu X; Xia J; Shi J; Wang L; Lu W; Fan C
    ACS Appl Mater Interfaces; 2018 Jan; 10(4):3414-3420. PubMed ID: 29299920
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cysteine modified and bile salt based micelles: preparation and application as an oral delivery system for paclitaxel.
    Xu W; Fan X; Zhao Y; Li L
    Colloids Surf B Biointerfaces; 2015 Apr; 128():165-171. PubMed ID: 25747310
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Retro-inverso isomer of Angiopep-2: a stable d-peptide ligand inspires brain-targeted drug delivery.
    Wei X; Zhan C; Chen X; Hou J; Xie C; Lu W
    Mol Pharm; 2014 Oct; 11(10):3261-8. PubMed ID: 24673510
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pluronic F127-Modified Electrospun Fibrous Meshes for Synergistic Combination Chemotherapy of Colon Cancer.
    Xie D; Ma P; Ding X; Yang X; Duan L; Xiao B; Yi S
    Front Bioeng Biotechnol; 2020; 8():618516. PubMed ID: 33665187
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Controlled delivery of recombinant hirudin based on thermo-sensitive Pluronic F127 hydrogel for subcutaneous administration: In vitro and in vivo characterization.
    Liu Y; Lu WL; Wang JC; Zhang X; Zhang H; Wang XQ; Zhou TY; Zhang Q
    J Control Release; 2007 Feb; 117(3):387-95. PubMed ID: 17207884
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Angiopep-2/IP10-EGFRvIIIscFv modified nanoparticles and CTL synergistically inhibit malignant glioblastoma.
    Wang X; Xiong Z; Liu Z; Huang X; Jiang X
    Sci Rep; 2018 Aug; 8(1):12827. PubMed ID: 30150691
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Thermosensitive hydrogels of poly(methyl vinyl ether-co-maleic anhydride) - Pluronic(®) F127 copolymers for controlled protein release.
    Moreno E; Schwartz J; Larrañeta E; Nguewa PA; Sanmartín C; Agüeros M; Irache JM; Espuelas S
    Int J Pharm; 2014 Jan; 459(1-2):1-9. PubMed ID: 24315923
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.